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Introduction: Lobectomy is standard treatment for early lung cancer, with 
lobectomy by thoracotomy and video-assisted thoracic surgery (VATS) as the 
most common types. Some studies have shown that VATS lobectomy enables 
faster recovery of respiratory function than does thoracotomy because the 
former involves making only a small incision in the chest to access the lung. 
However, these studies featured only short-term follow-up periods. We 
evaluated and compared the advantages of VATS lobectomy and thoracotomy 
in terms of recovery of pulmonary function in patients with early lung cancer. 
We increased the follow-up period and analyzed respiratory recovery rate 
during the late postoperative phase. 
 
Methods: Data on 649 patients with early lung cancer who underwent VATS 
lobectomy and thoracotomy at Seoul University Hospital and Bundang Seoul 
University Hospital from January 2005 to December 2010 were 
retrospectively reviewed. We classified the patients into the VATS (n = 406) 
and thoracotomy groups (n = 243) and compared baseline characteristics, 
pulmonary function data including forced vital capacity (FVC), forced 
expiratory volume in 1 second (FEV1), and peak flow rate (PFR) at 3, 6, and 
12 months after surgery. 
 
Results: Among the 649 patients, the pulmonary function testing was 
conducted on 300, 497, and 362 cases at 3, 6, and 12 months after surgery and 
only 91 patients underwent all 3-, 6-, and 12-month pulmonary function tests. 
Repeated-measures analysis of covariance was performed on these 91 patients, 
and the 649 patients with missing data were analyzed by linear mixed effect 
ii 
 
model. All confounding factors that may have affected pulmonary function 
recovery were adjusted. Of the 91 patients, the VATS group exhibited a better 
FVC than did the thoracotomy group (p < 0.005). After analyzing the 649 
patients by linear mixed model, the VATS group also showed better FVC than 
that of the thoracotomy group and this effect had an interaction over time 
(103.66 ± 1.27 vs. 96.37 ± 1.49, p < 0.0001 at 6 months, 107.01 ± 1.30, 
100.28 ± 1.54, p = 0.0003 at 12 months). No significant differences were 
observed for in FEV1 or PFR. 
 
Conclusions: VATS lobectomy presented more advantages in terms of 
recovery of late postoperative FVC than did thoracotomy after surgery, but no 
significant group differences were observed in FEV1 and PFR. Long-lasting 
postoperative pain after thoracotomy is thought to be the cause of this result. 
---------------------------------------------------------------------------------------------- 
Keywords: lung cancer, lobectomy, surgical method, pulmonary function 
test 
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Lobectomy is standard treatment for resectable nonsmall cell lung cancer 
(NSCLC), but such procedures typically diminish lung function for a few 
weeks or months after surgery. Such a decline in lung function is influenced 
by preoperative pulmonary function, size of the resected lung, and the 
functional characteristics of the resected lung (1). In addition, few studies 
have discussed the differences in lung function recovery enabled by various 
surgical methods.  
Video-assisted thoracic surgery (VATS) and thoracotomy are widely used 
lobectomy procedures, but the former presents less postoperative pain and 
faster recovery because it entails making only a small incision in the chest to 
access the lung (2, 3). A number of studies have explored whether VATS 
patients exhibit superior recovery of lung function to that presented by 
patients who underwent thoracotomy (4, 5). Nakata et al. revealed that VATS 
lobectomy has advantageous effects on early postoperative pulmonary 
function (6). Although much progress has been made in research, previous 
studies have shown only early postoperative recovery of pulmonary function. 
We evaluated and compared the benefits that VATS lobectomy and 
thoracotomy provide in terms of pulmonary function recovery after lung 







We reviewed the medical records of 649 patients with clinical stage I or II 
resectable NSCLC who underwent lobectomy by VATS (n = 406) and 
thoracotomy (n = 243) at Seoul University Hospital and Bundang Seoul 
University Hospital from January 2005 to December 2010. The indications for 
VATS lobectomy were as follows: clinical stage I or II peripheral NSCLC; 
tumor < 5 cm in diameter. Only patients who satisfied the aforementioned 
preoperative indications were selected to compare the VATS group with the 
thoracotomy group. Patients who did not complete a postoperative follow-up 
pulmonary function test (PFT), had lung cancer with bronchial obstruction, 
and small cell lung cancer, as well as those who underwent sleeve lobectomy 
or bronchoplasty, bilobectomy, pneumonectomy, segmentectomy, or wedge 
resection were excluded. Data on age, sex, comorbidities, smoking history, 
pre and postoperative PFT, lung cancer stage, histology, and tumor location 
and size were collected.  
 
2. Operative procedure 
The latissimus dorsi and serratus anterior muscles were dissected during 
posterolateral thoracotomy. The thoracotomy was performed through the 
fourth or fifth intercostal space, and the two ribs were divided. VATS 
lobectomy was initiated by three incisions with rib sparing. Two incisions 
served as thoracoscopic ports and the third was an access thoracotomy 
incision made anteriorly in the fourth or fifth intercostal space. The latissimus 
dorsi was spared. Lymph node dissection was carried out in both the VATS 
and thoracotomy groups. The surgical approach was chosen based on clinical 
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attributes such as tumor size, patient age, general condition, and pulmonary 
function. The operative method was decided on by six attending thoracic 
surgeons who performed the operations.  
 
3. Pulmonary function test  
Pulmonary function data, including forced vital capacity (FVC), forced 
expiratory volume in 1 second (FEV1), and peak flow rate (PFR), were 
collected at preoperative and postoperative phases (i.e., 3, 6, and 12 months 
before and after surgery).  
 
4. Statistical analysis  
We divided the patients into two groups based on the surgical method for 
analysis. Baseline characteristics were analyzed with the Student’s t-test for 
continuous variables and the chi-square for categorical variables. A linear 
mixed model approach and repeated-measures analysis of covariance 
(ANCOVA) were performed to examine the relationship between surgical 
method and improvement in respiratory function over time. Factors that may 
have affected pulmonary function such as age, smoking history, history of 
lung disease, preoperative pulmonary function were included in the model and 
adjusted. Differences with a p-value < 0.05 were considered significant. The 











A total of 649 patients were analyzed. The VATS group included 406 cases 
and the thoracotomy group included 243 cases (Figure 1). Table 1 shows the 
baseline characteristics of the patients. No significant differences were found 
between the two groups, except those of sex, underlying lung disease, and 
PFR (Table 1). The most common histologic type was adenocarcinoma and 
stage I accounted for the highest percentage of progression. The VATS group 
included more patients with adenocarcinoma (p < 0.001) and stage I disease 
(p < 0.001). This group also exhibited smaller tumor sizes and a smaller 
number of dissected lymph nodes than those of the thoracotomy group (Table 
2). Lung function after surgery at 3-, 6-, and 12-months was analyzed. 
Because postoperative pulmonary function is affected by which lobe is 
resected, postoperative FVC and FEV1 are presented as percentages of 
predicted postoperative values in accordance with the formula of Nakahara 
(Figure 2) (7).  
 
 
Figure 1. Flow chart for the study design 




The postoperative changes in PFR were evaluated as percentages of 
preoperative values. The pulmonary function test data cover 300 (VATS: 197, 
thoracotomy: 103), 497 (VATS: 320, thoracotomy: 177), and 362 (VATS: 241, 
thoracotomy: 121) cases for 3, 6, and 12 months after surgery, respectively. 
Only 91 patients have performed all the 3-, 6-, 12-month pulmonary function 
tests. Among these 91 patients, the VATS group accounted for 72 patients and 
the thoracotomy group accounted for 19. 
 









217 (53.4) 155 (63.8) 0.010 
Age (year) 63.10 ± 9.69 63.65 ± 9.17 0.563 
Preoperative pulmonary function 
FEV1 (L) 2.46 ± 0.61 2.43 ± 0.63 0.750 
FVC (L) 3.44 ± 0.85 3.48 ± 0.85 0.858 
FEV1/FVC (%) 71.95 ± 9.72 70.62 ± 10.88 0.182 
Peak flow rate (%) 112.18 ± 21.98 107.63 ± 24.08 0.030 
Current or ex-
smoker, no. (%) 
175 (43.1) 121 (49.8) 0.098 
Pack year 15.16 ± 23.25 19.07 ± 25.43 0.030 
Comorbidities, no. (%) 
DM 45 (11.1) 29 (11.9) 0.741 
HTN 115 (28.3) 63 (25.9) 0.507 
Lung disease 54 (13.3) 52 (21.4) 0.007 
Heart disease 28 (6.9) 11(4.5) 0.219 




Table 2. Pathology and staging*  
 
 VATS 
(n = 406) 
Thoracotomy 
(n = 243) 
p value 
Tumor size (cm) 2.21 ± 0.99 2.72 ± 1.12 0.010 
No. of  
dissected lymph nodes  
21.39 ± 10.81 25.38 ± 13.39 0.001 
Pathology, no. (%) <0.001 
Adenocarcinoma 329 (81) 148 (60.9)  
Squamous  
cell carcinoma 
52 (12.8) 72 (29.6)  
Others 25(6.2) 23 (9.5)   
Pathological staging, no. (%) <0.001 
 Ia 308 (75.9) 135 (55.6)  
 Ib 62(15.3) 65 (26.7)  
 IIa 36 (8.9) 43 (17.7)  











Table 3 shows the baseline characteristics of the 91 patients. The repeated-
measures ANCOVA analysis showed that the VATS group exhibited a better 
FVC than did the thoracotomy group. At 3 months, 6 months, and 12 months 
after surgery, the recovery rate of FVC in the VATS group was 107.99 ± 
14.56%, 113. 97 ± 15.98%, 117.82 ± 16.90% for each and in thoracotomy 
group, the rates were 93.84 ± 20.34, 98.37 ± 18.91, 100.66 ± 17.69 for each (F 
= 13.527, p < 0.005). No interaction effect was observed between surgical 
method and time (F = 1.297, p = 0.276) (Table 4). Except for the FVC, no 
significant differences were found on the PFTs between the two groups after 
surgery (Table 4).  
Table 3. Baseline characteristics of the 91 patients* 
 
*Data are mean ± standard deviation or no. (%). 
 VATS 
(n = 72) 
Thoracotomy 
(n = 19) 
p value 
Gender (male),  
no (%) 
38 (52.8) 13 (68.4) 0.222 
Age (year)  63.33 ± 10.06 63.37 ± 11.02 0.564 
Preoperative pulmonary function  
FEV1 (L) 2.41 ± 0.54 2.21 ± 0.62 0.276  
FVC (L) 3.37 ± 0.71 3.28 ± 0.91 0.025  
FEV1/FVC (%) 71.74 ± 10.03 68.74 ± 12.97 0.241 
Peak flow rate (%)   109.57 ± 21.88 99.58 ± 24.87 0.326 
Current or  
ex-smoker, no. (%) 
33 (45.8) 10 (52.6) 0.598 
Pack year  16.88 ± 24.49 18.68 ± 20.67 0.630  
Comorbidities, no. (%)  
DM 8 (11.1) 1 (5.3) 0.448 
HTN 22 (30.6) 8 (42.1) 0.341 
Lung disease  13 (18.1) 6 (31.6) 0.197 


















































































































































































































































































































































































































































































































































































































































































































































All patients with missing data (n = 649) were analyzed using a linear mixed 
effect model (LME). We considered the interaction over the time to evaluate 
the differences of lung function recovery rate according to surgical method 
and adjusted for factors that may have affected the pulmonary function 
recovery, including age, sex, smoking, preoperative FEV1, and history of lung 
disease. The results of the LME-based analysis are shown in Tables 5 and 6. 
No time-dependent effects in FEV1 or PFR were observed after the LME was 
conducted. After adjusting for confounding factors, overall recovery of FEV1 
was 2.60% higher in the VATS group that that in the thoracotomy group, but 
it is not significant (p = 0.0834). Similarly, PFR was not significant (p = 
0.5415). However, a significant group × time interaction for recovery rate of 
FVC was observed (p = 0.0453), suggesting that the recovery rate in the VATS 
group improved over time. A post-hoc analysis was performed to compare the 
difference at the point of time and the adjusted p-value is presented after using 
Bonferroni method. The recovery rate of FVC in VATS groups was 4.0% 
higher than that of thoracotomy group 3 months after surgery, but the 
difference was not significant (98.25 ± 1.32 vs. 94.24 ± 1.60, p = 0.0762). The 
recovery rate of FVC was 7.29% higher (103.66 ± 1.27 vs. 96.37 ± 1.49, p 
<0.0001) and 6.73% higher (107.01 ± 1.30, 100.28 ± 1.54, p=0.0003) at 6 and 











Table 5. Estimated postoperative recovery rate in forced expiratory 
volume in 1 sec (FEV1) and peak flow rate (PFR) 
 





Table 6. Estimated postoperative forced vital capacity (FVC) 








  p-value† 
3 month after 
lobectomy 
VATS 98.25 ± 1.32  0.0762 
 Thoracotomy 94.24 ± 1.60   
6 month after 
lobectomy 
VATS 103.66 ± 1.27  <0.0001 
 Thoracotomy 96.37 ± 1.49   
12 month after 
lobectomy 
VATS 107.01 ± 1.30  0.0003 
  Thoracotomy 100.28 ± 1.54     
* Least square means, analyzed by linear mixed model effect  









     p-value  
FEV1 (%) VATS 104.12 ± 1.19  0.0834 
 Thoracotomy 101.52 ± 1.37   
PFR (%) VATS 83.77 ± 0.86  0.5415 















Lobectomies are frequently applied procedures for patients with lung cancer 
and thoracotomy is the standard method. However, the frequency of VATS 
lobectomy has increased, driving researchers to compare the advantages and 
disadvantages of these two surgical procedures. Thoracotomy enables access 
through a suitable surgical area, but it requires dissecting the thoracic muscles 
and ribs (8). VATS lobectomy involves fewer incisions, presents less 
postoperative pain, and enables faster recovery of respiratory function than 
does thoracotomy (2-4, 9). Therefore, the recovery of pulmonary function 
proceeds more quickly in patients who undergo VATS than that in patients 
who undergo thoracotomy. Nakata et al. compared the oxygenation degree 
and recovery of FEV1 and FVC in 21 patients who underwent VATS or 
thoracotomy, and found that the recovery of pulmonary function and 
oxygenation in the VATS group was superior to that in the thoracotomy group 
during the early postoperative period (6). However, no significant differences 
were found between the two groups 1 year after surgery. Qiang et al. verified 
pulmonary function in 102 patients with lung cancer at 1, 3, 7, 30, and 90 
days after lobectomy (10), and derived similar results. FVC recovery was 
delayed by up to 3 months after lobectomy in the thoracotomy group. The 
treatment appeared to have achieved superior FEV1 recovery, but no 
significant difference was found between the VATS and thoracotomy groups. 
The authors also measured pain scores on pre and postoperative days 1, 3, 7, 
30, and 90, and revealed that the pain score was significantly lower in the 
VATS group for up to a 3-month period. However, these previous studies only 
confirmed respiratory recovery during the early postoperative period. 
In this study, the recovery of lung function during the late postoperative phase 
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was analyzed. The FEV1 was not significantly different according to surgical 
method over the time by analyzed by the repeated-measures ANCOVA and 
linear mixed effect model. The FEV1 recovery rate reached the predicted 
postoperative value at 3 months in both the VATS and thoracotomy groups. 
These results are consistent with previous findings, indicating that the 
remaining lobe may need up to 3 months of adaptation or adjustment (11, 12). 
PFR reflects the change in a relatively large airway, but it did not reach the 
previous level and was not different. This result may have been due to 
removal of the large airway during the lobectomy. FVC recovery rate tended 
to be better in the VATS group than that in the thoracotomy group and the 
changes in lung function recovery over time were significant by the linear 
mixed model. The recovery rate of FVC did not reach the predicted 
100%value until 12 months in the thoracotomy group. Although we did not 
collect pain data, we believe that the pain after thoracotomy lasts much longer 
after lobectomy compared to that after VATS. One study demonstrated that 
long-term post-thoracotomy pain may persist for 12 months. The incidence 
rate of post-thoracotomy pain is 80% at 3 months, 75% at 6 months, and 61% 
one year (13). Another study suggested a relationship between postoperative 
pain and FVC recovery (10). Because the quality of life after lobectomy is 
important for patients with lung cancer, VATS lobectomy can be a more 
favorable procedure for patients requiring lobectomy. It can be particularly 
beneficial for elderly patients and patients with poor pulmonary function test 
results. However, VATS has a limitation for suitable surgical area compared to 
thoracotomy. Thus, the selection of a surgical method should be based on the 
advantages and disadvantages of each approach and determined by clinical 
significance. 
This study had some limitations that may be viewed as starting points for 
future research. Because lung perfusion scans were not performed, the exact 
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postoperative lung function could not be predicted. Nevertheless, checking 
perfusion scans would not have generated a huge difference in results because 
we used a formula suitable for resected lobes. Furthermore, retrospective data 
were used and propensity score matching was not used due to the large 
amount of missing data. Thus, the patients in the two groups were not 
perfectly matched. In addition, pre-operative lung function can affect recovery 
rate. To overcome these limitations, we chose an appropriate statistical model, 
and confounding factors were adjusted. Overall, the FVC recovery was better 
in the VATS group than that in the thoracotomy group, but the number of 
patients who has all serial PFT data was small (n = 91) and a group × time 
interaction was not observed. However, the analysis of all 649 patients 
showed a group × time interaction. This discrepancy occurred due to the 
number of patients. Despite these limitations, our study features a greater 
number of patients and provides confirmed results for long-term lung function 



















VATS lobectomy presented more advantages for recovery of late 
postoperative FVC after surgery than does thoracotomy after surgery. We 
hypothesize that pain after thoracotomy is more severe than that experienced 
after VATS lobectomy; such pain may persist for quite a long period and may 
affect the recovery rate of FVC. Further prospective studies will be necessary 
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서론 폐엽 절제술은 조기 폐암의 기본적인 치료이며, 폐엽 
절제술에는 비디오 흉강경 수술 혹은 개흉술이 가장 많이 쓰인다. 
몇몇 연구에서는, 수술 시 절개창이 작은 비디오 흉강경 그룹이 
호흡 기능의 회복에 있어 흉강경 보다 양호함을 보여 주었다. 
그러나 이들 연구는 수술 후 조기 폐기능만을 본 연구가 
대부분이었다. 이 연구의 목적은 비디오 흉강경 수술과 개흉술에서  
폐기능 회복을 비교하는 것으로, 추적 관찰 기간을 늘려 수술 후 
후기 폐기능을 관찰하고 분석하였다.  
 
방법 2005 년 1월부터 2010년 12월 까지 조기폐암으로 서울대병원 
및 분당 서울대병원에 입원하여 비디오 흉강경 수술 및 개흉술을 
받은 환자 649 명의 데이터를 후향적으로 분석하였다. 이 환자들을 
비디오 흉강경 군 (n=406) 과 개흉술 (n=243) 군으로 나누어 기본 
특성, 수술 전 및 수술 후 3개월, 6개월, 12개월 째 강제 폐활량 및 
1초간 강제 호기량, 최대 호기속도의 차이를 비교하였다. 
 
결과 649 명의 환자 중에서 수술 후 폐기능 검사는 3개월, 6개월 
12개월째 각각 300, 497, 362 건이 시행되었고, 91명만이 3개월, 6개월, 
12개월 자료를 모두 가지고 있었다. 이 91 명의 환자에는 반복 측정 
공분산 분석을, 결측치가 있는 649 명의 환자에게는 선형 혼합 
모델을 이용하여 결과를 분석하였다. 폐기능 회복에 영향을 미칠 수 
있는, 다른 혼란 변수들은 보정되었다. 91 명의 환자를 반복 측정 
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공분산 분석으로 분석하였을 때, 비디오 흉강경 그룹은 흉강경 
그룹에 비해 강제 폐활량 회복률이 양호함을 보여 주었다 (p < 
0.005). 649 명의 환자를 선형 혼합 모향으로 분석한 경우에도, 
비디오 흉강경 그룹은 흉강경 그룹보다 강제 폐활량 회복률이 
양호함을 보여주었고, 각 군에서 이러한 강제 폐활량 회복률의 변화 
정도는 시간에 따른 차이가 있었다 (6개월; 103.66 ± 1.27 vs. 96.37 ± 
1.49, p <0.0001, 12개월; 107.01 ± 1.30, 100.28 ± 1.54, p=0.0003). 그러나, 
1초간 강제 호기량 및 최대 호기속도 회복률은 수술 방법에 따른 
유의한 차이는 없었다. 
 
결론 비디오 흉강경 수술은 수술 후 후기 강제 폐활량 회복에 
있어서 개흉술보다 양호한 회복을 보이지만, 1초간 강제 호기량 및 
최대 호기속도 회복률은 수술 방법에 따른 차이는 보이지 않았다. 
개흉술 후에 지속되는 수술 후 통증이 이러한 결과의 원인일 
것으로 생각된다. 
---------------------------------------------------------------------------------------------- 
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Introduction: Lobectomy is standard treatment for early lung cancer, with 
lobectomy by thoracotomy and video-assisted thoracic surgery (VATS) as the 
most common types. Some studies have shown that VATS lobectomy enables 
faster recovery of respiratory function than does thoracotomy because the 
former involves making only a small incision in the chest to access the lung. 
However, these studies featured only short-term follow-up periods. We 
evaluated and compared the advantages of VATS lobectomy and thoracotomy 
in terms of recovery of pulmonary function in patients with early lung cancer. 
We increased the follow-up period and analyzed respiratory recovery rate 
during the late postoperative phase. 
 
Methods: Data on 649 patients with early lung cancer who underwent VATS 
lobectomy and thoracotomy at Seoul University Hospital and Bundang Seoul 
University Hospital from January 2005 to December 2010 were 
retrospectively reviewed. We classified the patients into the VATS (n = 406) 
and thoracotomy groups (n = 243) and compared baseline characteristics, 
pulmonary function data including forced vital capacity (FVC), forced 
expiratory volume in 1 second (FEV1), and peak flow rate (PFR) at 3, 6, and 
12 months after surgery. 
 
Results: Among the 649 patients, the pulmonary function testing was 
conducted on 300, 497, and 362 cases at 3, 6, and 12 months after surgery and 
only 91 patients underwent all 3-, 6-, and 12-month pulmonary function tests. 
Repeated-measures analysis of covariance was performed on these 91 patients, 
and the 649 patients with missing data were analyzed by linear mixed effect 
ii 
 
model. All confounding factors that may have affected pulmonary function 
recovery were adjusted. Of the 91 patients, the VATS group exhibited a better 
FVC than did the thoracotomy group (p < 0.005). After analyzing the 649 
patients by linear mixed model, the VATS group also showed better FVC than 
that of the thoracotomy group and this effect had an interaction over time 
(103.66 ± 1.27 vs. 96.37 ± 1.49, p < 0.0001 at 6 months, 107.01 ± 1.30, 
100.28 ± 1.54, p = 0.0003 at 12 months). No significant differences were 
observed for in FEV1 or PFR. 
 
Conclusions: VATS lobectomy presented more advantages in terms of 
recovery of late postoperative FVC than did thoracotomy after surgery, but no 
significant group differences were observed in FEV1 and PFR. Long-lasting 
postoperative pain after thoracotomy is thought to be the cause of this result. 
---------------------------------------------------------------------------------------------- 
Keywords: lung cancer, lobectomy, surgical method, pulmonary function 
test 
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Lobectomy is standard treatment for resectable nonsmall cell lung cancer 
(NSCLC), but such procedures typically diminish lung function for a few 
weeks or months after surgery. Such a decline in lung function is influenced 
by preoperative pulmonary function, size of the resected lung, and the 
functional characteristics of the resected lung (1). In addition, few studies 
have discussed the differences in lung function recovery enabled by various 
surgical methods.  
Video-assisted thoracic surgery (VATS) and thoracotomy are widely used 
lobectomy procedures, but the former presents less postoperative pain and 
faster recovery because it entails making only a small incision in the chest to 
access the lung (2, 3). A number of studies have explored whether VATS 
patients exhibit superior recovery of lung function to that presented by 
patients who underwent thoracotomy (4, 5). Nakata et al. revealed that VATS 
lobectomy has advantageous effects on early postoperative pulmonary 
function (6). Although much progress has been made in research, previous 
studies have shown only early postoperative recovery of pulmonary function. 
We evaluated and compared the benefits that VATS lobectomy and 
thoracotomy provide in terms of pulmonary function recovery after lung 







We reviewed the medical records of 649 patients with clinical stage I or II 
resectable NSCLC who underwent lobectomy by VATS (n = 406) and 
thoracotomy (n = 243) at Seoul University Hospital and Bundang Seoul 
University Hospital from January 2005 to December 2010. The indications for 
VATS lobectomy were as follows: clinical stage I or II peripheral NSCLC; 
tumor < 5 cm in diameter. Only patients who satisfied the aforementioned 
preoperative indications were selected to compare the VATS group with the 
thoracotomy group. Patients who did not complete a postoperative follow-up 
pulmonary function test (PFT), had lung cancer with bronchial obstruction, 
and small cell lung cancer, as well as those who underwent sleeve lobectomy 
or bronchoplasty, bilobectomy, pneumonectomy, segmentectomy, or wedge 
resection were excluded. Data on age, sex, comorbidities, smoking history, 
pre and postoperative PFT, lung cancer stage, histology, and tumor location 
and size were collected.  
 
2. Operative procedure 
The latissimus dorsi and serratus anterior muscles were dissected during 
posterolateral thoracotomy. The thoracotomy was performed through the 
fourth or fifth intercostal space, and the two ribs were divided. VATS 
lobectomy was initiated by three incisions with rib sparing. Two incisions 
served as thoracoscopic ports and the third was an access thoracotomy 
incision made anteriorly in the fourth or fifth intercostal space. The latissimus 
dorsi was spared. Lymph node dissection was carried out in both the VATS 
and thoracotomy groups. The surgical approach was chosen based on clinical 
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attributes such as tumor size, patient age, general condition, and pulmonary 
function. The operative method was decided on by six attending thoracic 
surgeons who performed the operations.  
 
3. Pulmonary function test  
Pulmonary function data, including forced vital capacity (FVC), forced 
expiratory volume in 1 second (FEV1), and peak flow rate (PFR), were 
collected at preoperative and postoperative phases (i.e., 3, 6, and 12 months 
before and after surgery).  
 
4. Statistical analysis  
We divided the patients into two groups based on the surgical method for 
analysis. Baseline characteristics were analyzed with the Student’s t-test for 
continuous variables and the chi-square for categorical variables. A linear 
mixed model approach and repeated-measures analysis of covariance 
(ANCOVA) were performed to examine the relationship between surgical 
method and improvement in respiratory function over time. Factors that may 
have affected pulmonary function such as age, smoking history, history of 
lung disease, preoperative pulmonary function were included in the model and 
adjusted. Differences with a p-value < 0.05 were considered significant. The 











A total of 649 patients were analyzed. The VATS group included 406 cases 
and the thoracotomy group included 243 cases (Figure 1). Table 1 shows the 
baseline characteristics of the patients. No significant differences were found 
between the two groups, except those of sex, underlying lung disease, and 
PFR (Table 1). The most common histologic type was adenocarcinoma and 
stage I accounted for the highest percentage of progression. The VATS group 
included more patients with adenocarcinoma (p < 0.001) and stage I disease 
(p < 0.001). This group also exhibited smaller tumor sizes and a smaller 
number of dissected lymph nodes than those of the thoracotomy group (Table 
2). Lung function after surgery at 3-, 6-, and 12-months was analyzed. 
Because postoperative pulmonary function is affected by which lobe is 
resected, postoperative FVC and FEV1 are presented as percentages of 
predicted postoperative values in accordance with the formula of Nakahara 
(Figure 2) (7).  
 
 
Figure 1. Flow chart for the study design 




The postoperative changes in PFR were evaluated as percentages of 
preoperative values. The pulmonary function test data cover 300 (VATS: 197, 
thoracotomy: 103), 497 (VATS: 320, thoracotomy: 177), and 362 (VATS: 241, 
thoracotomy: 121) cases for 3, 6, and 12 months after surgery, respectively. 
Only 91 patients have performed all the 3-, 6-, 12-month pulmonary function 
tests. Among these 91 patients, the VATS group accounted for 72 patients and 
the thoracotomy group accounted for 19. 
 









217 (53.4) 155 (63.8) 0.010 
Age (year) 63.10 ± 9.69 63.65 ± 9.17 0.563 
Preoperative pulmonary function 
FEV1 (L) 2.46 ± 0.61 2.43 ± 0.63 0.750 
FVC (L) 3.44 ± 0.85 3.48 ± 0.85 0.858 
FEV1/FVC (%) 71.95 ± 9.72 70.62 ± 10.88 0.182 
Peak flow rate (%) 112.18 ± 21.98 107.63 ± 24.08 0.030 
Current or ex-
smoker, no. (%) 
175 (43.1) 121 (49.8) 0.098 
Pack year 15.16 ± 23.25 19.07 ± 25.43 0.030 
Comorbidities, no. (%) 
DM 45 (11.1) 29 (11.9) 0.741 
HTN 115 (28.3) 63 (25.9) 0.507 
Lung disease 54 (13.3) 52 (21.4) 0.007 
Heart disease 28 (6.9) 11(4.5) 0.219 




Table 2. Pathology and staging*  
 
 VATS 
(n = 406) 
Thoracotomy 
(n = 243) 
p value 
Tumor size (cm) 2.21 ± 0.99 2.72 ± 1.12 0.010 
No. of  
dissected lymph nodes  
21.39 ± 10.81 25.38 ± 13.39 0.001 
Pathology, no. (%) <0.001 
Adenocarcinoma 329 (81) 148 (60.9)  
Squamous  
cell carcinoma 
52 (12.8) 72 (29.6)  
Others 25(6.2) 23 (9.5)   
Pathological staging, no. (%) <0.001 
 Ia 308 (75.9) 135 (55.6)  
 Ib 62(15.3) 65 (26.7)  
 IIa 36 (8.9) 43 (17.7)  











Table 3 shows the baseline characteristics of the 91 patients. The repeated-
measures ANCOVA analysis showed that the VATS group exhibited a better 
FVC than did the thoracotomy group. At 3 months, 6 months, and 12 months 
after surgery, the recovery rate of FVC in the VATS group was 107.99 ± 
14.56%, 113. 97 ± 15.98%, 117.82 ± 16.90% for each and in thoracotomy 
group, the rates were 93.84 ± 20.34, 98.37 ± 18.91, 100.66 ± 17.69 for each (F 
= 13.527, p < 0.005). No interaction effect was observed between surgical 
method and time (F = 1.297, p = 0.276) (Table 4). Except for the FVC, no 
significant differences were found on the PFTs between the two groups after 
surgery (Table 4).  
Table 3. Baseline characteristics of the 91 patients* 
 
*Data are mean ± standard deviation or no. (%). 
 VATS 
(n = 72) 
Thoracotomy 
(n = 19) 
p value 
Gender (male),  
no (%) 
38 (52.8) 13 (68.4) 0.222 
Age (year)  63.33 ± 10.06 63.37 ± 11.02 0.564 
Preoperative pulmonary function  
FEV1 (L) 2.41 ± 0.54 2.21 ± 0.62 0.276  
FVC (L) 3.37 ± 0.71 3.28 ± 0.91 0.025  
FEV1/FVC (%) 71.74 ± 10.03 68.74 ± 12.97 0.241 
Peak flow rate (%)   109.57 ± 21.88 99.58 ± 24.87 0.326 
Current or  
ex-smoker, no. (%) 
33 (45.8) 10 (52.6) 0.598 
Pack year  16.88 ± 24.49 18.68 ± 20.67 0.630  
Comorbidities, no. (%)  
DM 8 (11.1) 1 (5.3) 0.448 
HTN 22 (30.6) 8 (42.1) 0.341 
Lung disease  13 (18.1) 6 (31.6) 0.197 


















































































































































































































































































































































































































































































































































































































































































































































All patients with missing data (n = 649) were analyzed using a linear mixed 
effect model (LME). We considered the interaction over the time to evaluate 
the differences of lung function recovery rate according to surgical method 
and adjusted for factors that may have affected the pulmonary function 
recovery, including age, sex, smoking, preoperative FEV1, and history of lung 
disease. The results of the LME-based analysis are shown in Tables 5 and 6. 
No time-dependent effects in FEV1 or PFR were observed after the LME was 
conducted. After adjusting for confounding factors, overall recovery of FEV1 
was 2.60% higher in the VATS group that that in the thoracotomy group, but 
it is not significant (p = 0.0834). Similarly, PFR was not significant (p = 
0.5415). However, a significant group × time interaction for recovery rate of 
FVC was observed (p = 0.0453), suggesting that the recovery rate in the VATS 
group improved over time. A post-hoc analysis was performed to compare the 
difference at the point of time and the adjusted p-value is presented after using 
Bonferroni method. The recovery rate of FVC in VATS groups was 4.0% 
higher than that of thoracotomy group 3 months after surgery, but the 
difference was not significant (98.25 ± 1.32 vs. 94.24 ± 1.60, p = 0.0762). The 
recovery rate of FVC was 7.29% higher (103.66 ± 1.27 vs. 96.37 ± 1.49, p 
<0.0001) and 6.73% higher (107.01 ± 1.30, 100.28 ± 1.54, p=0.0003) at 6 and 











Table 5. Estimated postoperative recovery rate in forced expiratory 
volume in 1 sec (FEV1) and peak flow rate (PFR) 
 





Table 6. Estimated postoperative forced vital capacity (FVC) 








  p-value† 
3 month after 
lobectomy 
VATS 98.25 ± 1.32  0.0762 
 Thoracotomy 94.24 ± 1.60   
6 month after 
lobectomy 
VATS 103.66 ± 1.27  <0.0001 
 Thoracotomy 96.37 ± 1.49   
12 month after 
lobectomy 
VATS 107.01 ± 1.30  0.0003 
  Thoracotomy 100.28 ± 1.54     
* Least square means, analyzed by linear mixed model effect  









     p-value  
FEV1 (%) VATS 104.12 ± 1.19  0.0834 
 Thoracotomy 101.52 ± 1.37   
PFR (%) VATS 83.77 ± 0.86  0.5415 















Lobectomies are frequently applied procedures for patients with lung cancer 
and thoracotomy is the standard method. However, the frequency of VATS 
lobectomy has increased, driving researchers to compare the advantages and 
disadvantages of these two surgical procedures. Thoracotomy enables access 
through a suitable surgical area, but it requires dissecting the thoracic muscles 
and ribs (8). VATS lobectomy involves fewer incisions, presents less 
postoperative pain, and enables faster recovery of respiratory function than 
does thoracotomy (2-4, 9). Therefore, the recovery of pulmonary function 
proceeds more quickly in patients who undergo VATS than that in patients 
who undergo thoracotomy. Nakata et al. compared the oxygenation degree 
and recovery of FEV1 and FVC in 21 patients who underwent VATS or 
thoracotomy, and found that the recovery of pulmonary function and 
oxygenation in the VATS group was superior to that in the thoracotomy group 
during the early postoperative period (6). However, no significant differences 
were found between the two groups 1 year after surgery. Qiang et al. verified 
pulmonary function in 102 patients with lung cancer at 1, 3, 7, 30, and 90 
days after lobectomy (10), and derived similar results. FVC recovery was 
delayed by up to 3 months after lobectomy in the thoracotomy group. The 
treatment appeared to have achieved superior FEV1 recovery, but no 
significant difference was found between the VATS and thoracotomy groups. 
The authors also measured pain scores on pre and postoperative days 1, 3, 7, 
30, and 90, and revealed that the pain score was significantly lower in the 
VATS group for up to a 3-month period. However, these previous studies only 
confirmed respiratory recovery during the early postoperative period. 
In this study, the recovery of lung function during the late postoperative phase 
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was analyzed. The FEV1 was not significantly different according to surgical 
method over the time by analyzed by the repeated-measures ANCOVA and 
linear mixed effect model. The FEV1 recovery rate reached the predicted 
postoperative value at 3 months in both the VATS and thoracotomy groups. 
These results are consistent with previous findings, indicating that the 
remaining lobe may need up to 3 months of adaptation or adjustment (11, 12). 
PFR reflects the change in a relatively large airway, but it did not reach the 
previous level and was not different. This result may have been due to 
removal of the large airway during the lobectomy. FVC recovery rate tended 
to be better in the VATS group than that in the thoracotomy group and the 
changes in lung function recovery over time were significant by the linear 
mixed model. The recovery rate of FVC did not reach the predicted 
100%value until 12 months in the thoracotomy group. Although we did not 
collect pain data, we believe that the pain after thoracotomy lasts much longer 
after lobectomy compared to that after VATS. One study demonstrated that 
long-term post-thoracotomy pain may persist for 12 months. The incidence 
rate of post-thoracotomy pain is 80% at 3 months, 75% at 6 months, and 61% 
one year (13). Another study suggested a relationship between postoperative 
pain and FVC recovery (10). Because the quality of life after lobectomy is 
important for patients with lung cancer, VATS lobectomy can be a more 
favorable procedure for patients requiring lobectomy. It can be particularly 
beneficial for elderly patients and patients with poor pulmonary function test 
results. However, VATS has a limitation for suitable surgical area compared to 
thoracotomy. Thus, the selection of a surgical method should be based on the 
advantages and disadvantages of each approach and determined by clinical 
significance. 
This study had some limitations that may be viewed as starting points for 
future research. Because lung perfusion scans were not performed, the exact 
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postoperative lung function could not be predicted. Nevertheless, checking 
perfusion scans would not have generated a huge difference in results because 
we used a formula suitable for resected lobes. Furthermore, retrospective data 
were used and propensity score matching was not used due to the large 
amount of missing data. Thus, the patients in the two groups were not 
perfectly matched. In addition, pre-operative lung function can affect recovery 
rate. To overcome these limitations, we chose an appropriate statistical model, 
and confounding factors were adjusted. Overall, the FVC recovery was better 
in the VATS group than that in the thoracotomy group, but the number of 
patients who has all serial PFT data was small (n = 91) and a group × time 
interaction was not observed. However, the analysis of all 649 patients 
showed a group × time interaction. This discrepancy occurred due to the 
number of patients. Despite these limitations, our study features a greater 
number of patients and provides confirmed results for long-term lung function 



















VATS lobectomy presented more advantages for recovery of late 
postoperative FVC after surgery than does thoracotomy after surgery. We 
hypothesize that pain after thoracotomy is more severe than that experienced 
after VATS lobectomy; such pain may persist for quite a long period and may 
affect the recovery rate of FVC. Further prospective studies will be necessary 
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서론 폐엽 절제술은 조기 폐암의 기본적인 치료이며, 폐엽 
절제술에는 비디오 흉강경 수술 혹은 개흉술이 가장 많이 쓰인다. 
몇몇 연구에서는, 수술 시 절개창이 작은 비디오 흉강경 그룹이 
호흡 기능의 회복에 있어 흉강경 보다 양호함을 보여 주었다. 
그러나 이들 연구는 수술 후 조기 폐기능만을 본 연구가 
대부분이었다. 이 연구의 목적은 비디오 흉강경 수술과 개흉술에서  
폐기능 회복을 비교하는 것으로, 추적 관찰 기간을 늘려 수술 후 
후기 폐기능을 관찰하고 분석하였다.  
 
방법 2005 년 1월부터 2010년 12월 까지 조기폐암으로 서울대병원 
및 분당 서울대병원에 입원하여 비디오 흉강경 수술 및 개흉술을 
받은 환자 649 명의 데이터를 후향적으로 분석하였다. 이 환자들을 
비디오 흉강경 군 (n=406) 과 개흉술 (n=243) 군으로 나누어 기본 
특성, 수술 전 및 수술 후 3개월, 6개월, 12개월 째 강제 폐활량 및 
1초간 강제 호기량, 최대 호기속도의 차이를 비교하였다. 
 
결과 649 명의 환자 중에서 수술 후 폐기능 검사는 3개월, 6개월 
12개월째 각각 300, 497, 362 건이 시행되었고, 91명만이 3개월, 6개월, 
12개월 자료를 모두 가지고 있었다. 이 91 명의 환자에는 반복 측정 
공분산 분석을, 결측치가 있는 649 명의 환자에게는 선형 혼합 
모델을 이용하여 결과를 분석하였다. 폐기능 회복에 영향을 미칠 수 
있는, 다른 혼란 변수들은 보정되었다. 91 명의 환자를 반복 측정 
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공분산 분석으로 분석하였을 때, 비디오 흉강경 그룹은 흉강경 
그룹에 비해 강제 폐활량 회복률이 양호함을 보여 주었다 (p < 
0.005). 649 명의 환자를 선형 혼합 모향으로 분석한 경우에도, 
비디오 흉강경 그룹은 흉강경 그룹보다 강제 폐활량 회복률이 
양호함을 보여주었고, 각 군에서 이러한 강제 폐활량 회복률의 변화 
정도는 시간에 따른 차이가 있었다 (6개월; 103.66 ± 1.27 vs. 96.37 ± 
1.49, p <0.0001, 12개월; 107.01 ± 1.30, 100.28 ± 1.54, p=0.0003). 그러나, 
1초간 강제 호기량 및 최대 호기속도 회복률은 수술 방법에 따른 
유의한 차이는 없었다. 
 
결론 비디오 흉강경 수술은 수술 후 후기 강제 폐활량 회복에 
있어서 개흉술보다 양호한 회복을 보이지만, 1초간 강제 호기량 및 
최대 호기속도 회복률은 수술 방법에 따른 차이는 보이지 않았다. 
개흉술 후에 지속되는 수술 후 통증이 이러한 결과의 원인일 
것으로 생각된다. 
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